An Investigational Scan (rh PSMA 7.3 PET/MRI) for the Detection of Recurrent Disease and Aid in Radiotherapy Planning in Biochemically Recurrent Prostate Cancer

NCT04978675 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Biochemically Recurrent Prostate Carcinoma
Localized Prostate Carcinoma
Prostate Adenocarcinoma

Interventions

DRUG: Fluorine F 18 rhPSMA-7.3
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography

Sponsor

M.D. Anderson Cancer Center